CRD to establish £40m bio-therapeutics hub in Aberdeen, Scotland
November 25, 2018 – Aberdeen City Region Deal (CRD), a partnership between Aberdeen City and Aberdeenshire Councils and private sector-led economic development body Opportunity North East (ONE), is establishing a £40m Bio-therapeutics Hub for Innovation in Aberdeen, Scotland.
The hub will double the number of life sciences companies in North East Scotland and support the sector’s ambitions to collaborate, innovate and commercialise new therapies and healthcare solutions.
It has secured £20m of capital funding from the UK and Scottish governments through the CRD.
ONE, which led the development of the project with partners, has committed an additional £3.6m over seven years to operate the hub and deliver the support activity to make Aberdeen a dynamic environment to create and grow life sciences businesses.
The project also supports regional economic diversification, increasing the Scottish sector to £8bn turnover by 2025, and creating a life sciences ecosystem in the UK with collaboration with industry, the NHS, academia and research funders.
ONE team is leading the delivery of the project, which has been developed by ONE Life Sciences sector board, University of Aberdeen, Robert Gordon University, NHS Grampian and Scottish Enterprise.
The hub will be established on Foresterhill Health Campus, one of Europe’s largest integrated clinical, research, teaching and commercial health sites.
The 69,000ft² new-build facility will include accommodation for spin-outs, start-ups and established companies; collaboration space; and shared facilities for events, conferences and networking.
Support programmes will include incubation, acceleration, mentoring, commercialisation and growth planning.
The hub will also promote international collaborations and investment into research and companies.
A design team has been appointed for the project. A planning application will be submitted in 2019 and construction is scheduled to start later in 2019. The hub is expected to be opened in December 2020.
ONE Life Sciences sector board chair Prof Stephen Logan said: “Creating the innovation hub for new, early-stage and established life sciences and healthcare businesses is at the heart of our ambition to build a dynamic company cluster.
“It draws on the significant assets in and around the Foresterhill Health Campus in Aberdeen. The hub will realise the opportunity to collaborate and innovate to bring forward the next generation of medical therapies and products and our target is to double the size of the company base by 2027.”